全文获取类型
收费全文 | 183篇 |
免费 | 18篇 |
国内免费 | 2篇 |
专业分类
儿科学 | 13篇 |
基础医学 | 21篇 |
口腔科学 | 2篇 |
临床医学 | 22篇 |
内科学 | 34篇 |
皮肤病学 | 6篇 |
神经病学 | 9篇 |
特种医学 | 51篇 |
外科学 | 15篇 |
综合类 | 2篇 |
预防医学 | 11篇 |
眼科学 | 1篇 |
药学 | 10篇 |
肿瘤学 | 6篇 |
出版年
2022年 | 2篇 |
2021年 | 4篇 |
2020年 | 2篇 |
2019年 | 2篇 |
2018年 | 2篇 |
2017年 | 1篇 |
2016年 | 2篇 |
2015年 | 8篇 |
2014年 | 2篇 |
2013年 | 7篇 |
2012年 | 2篇 |
2011年 | 1篇 |
2010年 | 7篇 |
2009年 | 6篇 |
2008年 | 3篇 |
2007年 | 3篇 |
2006年 | 1篇 |
2005年 | 2篇 |
2004年 | 2篇 |
2003年 | 4篇 |
2002年 | 6篇 |
2001年 | 1篇 |
2000年 | 3篇 |
1999年 | 1篇 |
1998年 | 15篇 |
1997年 | 9篇 |
1996年 | 9篇 |
1995年 | 13篇 |
1994年 | 10篇 |
1993年 | 7篇 |
1992年 | 2篇 |
1991年 | 1篇 |
1990年 | 5篇 |
1989年 | 2篇 |
1988年 | 6篇 |
1987年 | 10篇 |
1986年 | 4篇 |
1985年 | 8篇 |
1984年 | 11篇 |
1983年 | 1篇 |
1982年 | 4篇 |
1981年 | 2篇 |
1980年 | 2篇 |
1978年 | 1篇 |
1977年 | 2篇 |
1976年 | 4篇 |
1962年 | 1篇 |
排序方式: 共有203条查询结果,搜索用时 15 毫秒
81.
BRCA1 is a tumor suppressor with critical roles in the maintenance of genomic stability. It encodes a large protein with an amino-terminal RING domain that possesses ubiquitin-ligase activity. Given the occurrence of numerous cancer-causing mutations within its RING domain, investigators have long suspected that BRCA1's ubiquitin ligase is important for its tumor suppression and DNA repair activities. Using genetically engineered mouse models, two recent studies shed light on this age-old hypothesis. 相似文献
82.
Jorieke EH Bergman Erika A Bosman Conny MA van Ravenswaaij-Arts Karen P Steel 《European journal of human genetics : EJHG》2010,18(2):171-177
CHARGE syndrome is a multiple congenital anomaly syndrome characterised by Coloboma, Heart defects, Atresia of choanae, Retardation of growth and/or development, Genital hypoplasia, and Ear anomalies often associated with deafness. It is caused by heterozygous mutations in the CHD7 gene and shows a highly variable phenotype. Anosmia and hypogonadotropic hypogonadism occur in the majority of the CHARGE patients, but the underlying pathogenesis is unknown. Therefore, we studied the ability to smell and aspects of the reproductive system (reproductive performance, gonadotropin-releasing hormone (GnRH) neurons and anatomy of testes and uteri) in a mouse model for CHARGE syndrome, the whirligig mouse (Chd7Whi/+). We showed that Chromodomain Helicase DNA-binding protein 7 (Chd7) is expressed in brain areas involved in olfaction and reproduction during embryonic development. We observed poorer performance in the smell test in adult Chd7Whi/+ mice, secondary either to olfactory dysfunction or to balance disturbances. Olfactory bulb and reproductive organ abnormalities were observed in a proportion of Chd7Whi/+ mice. Hypothalamic GnRH neurons were slightly reduced in Chd7Whi/+ females and reproductive performance was slightly less in Chd7Whi/+ mice. This study shows that the penetrance of anosmia and hypogonadotropic hypogonadism is lower in Chd7Whi/+ mice than in CHARGE patients. Interestingly, many phenotypic features of the Chd7 mutation showed incomplete penetrance in our model mice, despite the use of inbred, genetically identical mice. This supports the theory that the extreme variability of the CHARGE phenotype in both humans and mice might be attributed to variations in the fetal microenvironment or to purely stochastic events. 相似文献
83.
Low-dose deoxycoformycin in the treatment of hairy cell leukemia 总被引:3,自引:3,他引:3
Ten patients with progressive hairy cell leukemia were treated with 2'deoxycoformycin (dCF) by intravenous bolus (4 mg/m2) given every other week. All ten patients are evaluable for response and nine of the ten patients have achieved a complete remission. In addition to clearing of hairy cells from the bone marrow, eight patients had resolution of their monocytopenia. Seven of the nine patients remain in unmaintained remission with a median duration of 6.2 months. Two patients have had relapse in the bone marrow alone and continue to have normal peripheral blood counts. They are being followed without treatment. Toxicity was minimal at this low dose with one patient having a mild reversible reduction in creatinine clearance. Four other patients had reversible neutropenia. There were no significant infections associated with treatment. Low-dose deoxycoformycin administered intravenously every other week represents an extremely effective treatment for hairy cell leukemia. 相似文献
84.
Hatem M Abuohashish Mohammed M Ahmed Salim S Al-Rejaie Kamal EH Eltahir 《Acta pharmacologica Sinica》2015,36(2):209-220
Aim:
Depression is a risk factor for impaired bone mass and micro-architecture, but several antidepressants were found to increase the incidence of osteoporotic fractures. In the present study we used ovariectomized (OVX) rats as a model of osteoporosis to investigate the effects of the antidepressant bupropion on the femoral bones.Methods:
OVX animals were treated with bupropion (30, 60 mg·kg−1·d−1) for six weeks. Bone turnover biomarkers (urinary DPD/Cr ratio, serum BALP, OC, TRAcP 5b, CTX and sRANKL levels) and inflammatory cytokines (TNF-α, IL-1β and IL-6) were determined using ELISA. Inductively coupled plasma mass spectroscopy (ICP-MS) was used to determine the femoral bone mineral concentrations. The cortical and trabecular morphometric parameters of femoral bones were determined using micro-CT scan and histopathology.Results:
In OVX rats, the levels of bone turnover biomarkers and inflammatory cytokines were significantly elevated and femoral bone Ca2+ and PO43− concentrations were significantly reduced. Moreover, cortical and trabecular morphometric parameters and histopathology of femoral bones were severely altered by ovariectomy. Bupropion dose-dependently inhibited the increases in bone turnover biomarkers and inflammatory cytokines. OVX rats treated with the high dose of bupropion showed normal mineral concentrations in femoral bones. The altered morphometric parameters and histopathology of femoral bones were markedly attenuated by the treatment.Conclusion:
Bupropion exerts osteo-protective action in OVX rats through suppressing osteoclastogenesis-inducing factors and inflammation, which stabilize the osteoclasts and decrease bone matrix degradation or resorption. 相似文献85.
86.
87.
A randomized controlled trial of single‐class maintenance therapy with abacavir/lamivudine/zidovudine after standard triple antiretroviral induction therapy: final 96‐week results from the FREE study 下载免费PDF全文
88.
Overexpression of adenosine deaminase (ADA) in red blood cells is characterized by a marked, tissue-specific increase in levels of structurally normal ADA mRNA and enzymatic activity in the erythrocytes of affected individuals, leading to adenosine triphosphate (ATP) depletion and hemolytic anemia. This autosomal dominant trait is linked to the ADA gene. To investigate the molecular mechanism responsible for this disorder, we examined relative reporter gene activity using constructs containing 10.6 kb of 5' flanking sequence and 12.3 kb of the first intron of the ADA gene from the normal and mutant alleles. No differences in chloramphenicol acetyltransferase (CAT) activity were found in transient transfection experiments using erythroleukemia cell lines. Transgenic mice containing the ADA constructs expressed CAT in the appropriate tissue-specific fashion, with 10(2)- to 10(4)-fold higher activity in the thymus. However, CAT activities in erythrocytes and bone marrow of mice containing high transgene copy numbers did not differ between the normal and mutant alleles. These results indicate that the mutation responsible for ADA overexpression is unlikely to reside in the 5' and promoter regions or in the regulatory regions of the first intron. It is possible that the erythroid-specific overexpression of ADA results from a mutation at some distance from the gene or requires an interaction of a proximal mutation with more distal DNA elements. 相似文献
89.
Monoclonal antibody therapy in rheumatoid arthritis 总被引:1,自引:0,他引:1
Monoclonal antibodies bind to their targets with high specificity and
therefore have excellent potential as therapeutic agents. Biotechnological
advances have allowed the production of large quantities of engineered
monoclonal antibodies for therapeutic use. Recent research in rheumatoid
arthritis has identified important mediators of synovitis. Monoclonal
antibodies targeting these have been tested in clinical trials over the
last decade. Anti-cytokine therapies, in particular anti-tumour necrosis
factor alpha monoclonal antibodies, suppressed inflammation and produced
rapid symptomatic improvement. Anti-lymphocyte monoclonal antibodies
produced long- lasting disease suppression in animal models of rheumatoid
arthritis. The use of depleting anti-lymphocyte monoclonal antibodies in
rheumatoid arthritis had been disappointing as they did not penetrate the
synovial joint in sufficient quantity to suppress disease without producing
severe and protracted peripheral blood lymphopenia. Consequently, their use
in rheumatoid arthritis had been abandoned. In contrast, clinical trials of
non-depleting anti-CD4 monoclonal antibodies in rheumatoid arthritis showed
that they could suppress synovitis. However, it remains unclear whether
they could lead to prolonged disease improvement.
相似文献
90.
HJ Ng M Yule M Twoon NR Binnie EH Aly 《Annals of the Royal College of Surgeons of England》2015,97(2):151-156